Home/Filings/4/0001127602-09-010091
4//SEC Filing

Ordemann Thomas 4

Accession 0001127602-09-010091

CIK 0001014739other

Filed

Apr 29, 8:00 PM ET

Accepted

Apr 30, 3:12 PM ET

Size

8.7 KB

Accession

0001127602-09-010091

Insider Transaction Report

Form 4
Period: 2009-04-28
Ordemann Thomas
Executive Vice President
Transactions
  • Award

    Option To Purchase Common Stock

    2009-04-28+75,00075,000 total
    Exercise: $2.73From: 2010-04-28Exp: 2019-04-28Common Stock, $.0001 Par Value (75,000 underlying)
Holdings
  • Option To Purchase Common Stock

    Exercise: $5.46From: 2008-08-01Exp: 2017-08-01Common Stock, $.0001 Par Value (80,000 underlying)
    80,000
  • Option To Purchase Common Stock

    Exercise: $6.52From: 2009-04-29Exp: 2018-04-29Common Stock, $.0001 Par Value (50,625 underlying)
    50,625
  • Common Stock, $.0001 Par Value

    46,063
Footnotes (1)
  • [F1]Vests and becomes exercisable in three equal annual installments commencing on the first anniversary of the date of grant.

Issuer

BioScrip, Inc.

CIK 0001014739

Entity typeother

Related Parties

1
  • filerCIK 0001430965

Filing Metadata

Form type
4
Filed
Apr 29, 8:00 PM ET
Accepted
Apr 30, 3:12 PM ET
Size
8.7 KB